Department of Respiratory Medicine, Okinawa Chubu Hospital.
Department of Intensive Care Unit, Okinawa Chubu Hospital.
Tohoku J Exp Med. 2022 Feb;256(2):127-130. doi: 10.1620/tjem.256.127.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sometimes causes severe coronavirus disease 2019 (COVID-19) pneumonia. Here, we report the case of a 35-year-old man with obesity who showed severe respiratory failure from SARS-CoV-2 infection. Immediate high-resolution computed tomography (HRCT) of the chest after endotracheal intubation revealed a significant pneumomediastinum with diffuse ground-glass opacity and consolidation. Ventilator management was difficult with low tidal volume and low positive end expiratory pressure. Therefore, we administered extracorporeal membrane oxygenation (ECMO) to allow lung rest and prevent further progression of the pneumomediastinum and maintain oxygenation. Since implementing ECMO, the patient's oxygenation has stabilized and follow-up HRCT of the chest revealed dramatic improvement of the pneumomediastinum. We gradually tapered off ECMO and employed a pressure-control mode. He was extubated on day 11. To our knowledge, this is the first reported patient who showed complete pneumomediastinum recovery from COVID-19 pneumonia with ECMO.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)有时会引起严重的 2019 年冠状病毒病(COVID-19)肺炎。在这里,我们报告了一例肥胖的 35 岁男性,他因 SARS-CoV-2 感染出现严重呼吸衰竭。气管插管后立即进行高分辨率胸部计算机断层扫描(HRCT)显示明显的纵隔气肿,伴有弥漫性磨玻璃影和实变。由于低潮气量和低呼气末正压通气,呼吸机管理困难。因此,我们给予体外膜氧合(ECMO)以允许肺部休息,防止纵隔气肿进一步进展并维持氧合。自实施 ECMO 以来,患者的氧合稳定,胸部 HRCT 随访显示纵隔气肿明显改善。我们逐渐减少 ECMO 并采用压力控制模式。他在第 11 天拔管。据我们所知,这是首例报告的 COVID-19 肺炎患者,经 ECMO 治疗后完全恢复纵隔气肿。